Right Versus Left Prefrontal Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Preliminary Investigation
J Clin Psychiatry 2001;62(12):981-984
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: There is preliminary evidence that repetitive transcranial
magnetic stimulation (rTMS) may be useful for the treatment of obsessive-compulsive
disorder (OCD), but no definitive study has been published, and the effect of
laterality of stimulation is uncertain.
Method: Subjects (N = 12) with resistant OCD were allocated randomly
to either right or left prefrontal rTMS daily for 2 weeks and were assessed
by an independent rater at 1 and 2 weeks and 1 month later.
Results: Subjects had an overall significant improvement in the
obsessions (p < .01), compulsions (p < .01), and total (p < .01) scores
on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) after 2 weeks and at 1-month
follow-up. This improvement was significant for obsessions (p < .05) and
tended to significance for total Y-BOCS scores (p = .06) after correction for
changes in depression scores on the Montgomery-Asberg Depression Rating Scale.
There was no significant difference between right- and left-sided rTMS on any
of the parameters examined. Two subjects (33%) in each group showed a clinically
significant improvement that persisted at 1 month but with relapse later in
Conclusion: A proportion (about one quarter) of patients with
resistant OCD appear to respond to rTMS to either prefrontal lobe, although
in the absence of a sham treatment group in this study, we cannot rule out the
possibility of this being a placebo response. This treatment warrants further
investigation to better establish its efficacy and examine the best parameters